Clinical trial
COVID-19, Interleukin - 6 and Diurnal Salivary Cortisol
NCT04988269 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19, Interleukin - 6 and Diurnal Salivary Cortisol
- Lead sponsor
- National and Kapodistrian University of Athens
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2021
- Completion date
- July 28, 2021
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adrenal hyperfunction, adrenal insufficiency, covid-19